November 6, 2026

Raul Delapena Setiawan

ARUP Laboratories Advances Multiple Myeloma Diagnostics with Cutting-Edge Spectral Flow Cytometry arup-laboratories-advances-multiple-myeloma-diagnostics-with-cutting-edge-spectral-flow-cytometry

ARUP Laboratories Advances Multiple Myeloma Diagnostics with Cutting-Edge Spectral Flow Cytometry

Raul Delapena Setiawan July 22, 2026
In a significant leap forward for hematological oncology, ARUP Laboratories has officially launched the CLARISPECT Multiple Myeloma...
Read More Read more about ARUP Laboratories Advances Multiple Myeloma Diagnostics with Cutting-Edge Spectral Flow Cytometry
Canadian Breakthrough Offers New Hope for Young Cancer Patients with Personalized, Rapid Treatment canadian-breakthrough-offers-new-hope-for-young-cancer-patients-with-personalized-rapid-treatment

Canadian Breakthrough Offers New Hope for Young Cancer Patients with Personalized, Rapid Treatment

Raul Delapena Setiawan July 21, 2026
VANCOUVER, BC – In a landmark development that promises to revolutionize the treatment landscape for young cancer...
Read More Read more about Canadian Breakthrough Offers New Hope for Young Cancer Patients with Personalized, Rapid Treatment
Kolon TissueGene Faces Significant Setback as Knee Osteoarthritis Therapy Fails Phase III Trial, Stock Plummets kolon-tissuegene-faces-significant-setback-as-knee-osteoarthritis-therapy-fails-phase-iii-trial-stock-plummets

Kolon TissueGene Faces Significant Setback as Knee Osteoarthritis Therapy Fails Phase III Trial, Stock Plummets

Raul Delapena Setiawan July 21, 2026
Seoul, South Korea – [Insert Date] – Kolon TissueGene, a South Korean biopharmaceutical company, has experienced a...
Read More Read more about Kolon TissueGene Faces Significant Setback as Knee Osteoarthritis Therapy Fails Phase III Trial, Stock Plummets
Precision in Oncology: i31-SLNB Test Outperforms Traditional Nomograms in Melanoma Management precision-in-oncology-i31-slnb-test-outperforms-traditional-nomograms-in-melanoma-management

Precision in Oncology: i31-SLNB Test Outperforms Traditional Nomograms in Melanoma Management

Raul Delapena Setiawan July 21, 2026
In the evolving landscape of dermatological oncology, the quest to balance diagnostic precision with patient safety remains...
Read More Read more about Precision in Oncology: i31-SLNB Test Outperforms Traditional Nomograms in Melanoma Management
Unraveling the Heart of the Matter: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact unraveling-the-heart-of-the-matter-new-research-sheds-light-on-hormone-therapys-long-term-cardiovascular-impact

Unraveling the Heart of the Matter: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact

Raul Delapena Setiawan July 21, 2026
Main Facts The decision to initiate hormone therapy (HT) during the menopause transition, a pivotal life phase...
Read More Read more about Unraveling the Heart of the Matter: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact

You may have missed

a-new-dawn-for-aggressive-breast-cancers-cambridge-breakthrough-achieves-100-survival-in-landmark-trial

A New Dawn for Aggressive Breast Cancers: Cambridge Breakthrough Achieves 100% Survival in Landmark Trial

Asep Darmawan November 6, 2026
gilead-seeks-wider-use-for-livdelzi-on-phase-iii-liver-disease-success

Gilead seeks wider use for Livdelzi on Phase III liver disease success 

Lina Hope November 6, 2026
from-aspirations-to-adversity-an-international-students-journey-through-breast-cancer-and-resilience

From Aspirations to Adversity: An International Student’s Journey Through Breast Cancer and Resilience

Evan Lee Salim November 6, 2026
Young female scientist wearing lab coat and gloves carefully examining test tube with blue liquid, conducting research in modern laboratory with microscope and computer displaying dna structure

The Changing Paradigm of Metastatic Breast Cancer: From Terminal Diagnosis to Chronic Management

Siti Muinah November 6, 2026